av/genocea-biosciences--big.svg

COM:GENOCEA

AnnualReports.com

  • Stock

USD

Last Close

0.00

22/12 19:54

Volume Today

30.27K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
average inventory
average payables
1.81M
-
2.43M
34.18%
2.22M
8.61%
2.40M
7.89%
3.28M
36.65%
2.59M
21.10%
1.11M
57.26%
543.50K
50.86%
517K
4.88%
average receivables
92.50K
-
10.50K
88.65%
10.50K
0%
book value per share
0.66
-
16.65
2,404.22%
29.32
76.11%
12.87
56.10%
-1.69
113.14%
0.71
142.00%
1.21
70.67%
0.20
83.34%
0.39
95.33%
capex per share
-0.18
-
-0.78
330.75%
-0.91
16.95%
-0.72
21.20%
-0.33
54.08%
-0.02
92.91%
-0.05
135.43%
-0.06
5.81%
capex to depreciation
-1.22
-
-3.24
164.94%
-2.65
18.27%
-1.40
47.15%
-0.78
44.49%
-0.22
71.49%
-1.03
367.09%
-2.27
119.55%
capex to operating cash flow
0.02
-
0.06
181.31%
0.07
31.81%
0.06
16.42%
0.02
59.21%
0.01
76.38%
0.03
414.65%
0.06
106.33%
capex to revenue
-0.53
-
-4.94
827.39%
-4.16
15.80%
-10.80
159.91%
-1.90
-
cash per share
5.67
-
24.12
325.13%
30.85
27.93%
17.91
41.94%
3.43
80.84%
2.55
25.59%
1.94
23.90%
1.80
7.65%
0.54
69.82%
days of inventory on hand
days payables outstanding
days sales outstanding
24.89
-
debt to assets
0.91
-
0.36
60.91%
0.20
43.60%
0.35
73.82%
1.35
286.27%
0.76
43.22%
0.52
31.44%
0.91
73.43%
0.52
43.20%
debt to equity
10.01
-
0.55
94.49%
0.25
54.53%
0.53
113.29%
-3.89
827.49%
3.24
183.33%
1.10
66.04%
9.97
805.21%
1.07
89.29%
dividend yield
earnings yield
-0.11
-
-0.32
193.88%
-0.33
2.08%
-0.43
29.01%
-1.71
301.99%
-1.17
31.28%
-0.91
22.40%
-0.41
55.40%
-0.42
2.66%
enterprise value
186.97M
-
127.78M
31.66%
205.19M
60.59%
106.13M
48.28%
35.22M
66.82%
12.14M
65.53%
17.13M
41.11%
51.64M
201.46%
53.53M
3.66%
enterprise value over ebitda
-9.34
-
-3.77
59.57%
-5.09
34.86%
-2.31
54.69%
-0.66
71.45%
-0.47
28.26%
-0.46
1.73%
-1.25
170.07%
-1.56
24.44%
ev to operating cash flow
-9.41
-
-4.63
50.80%
-5.35
15.57%
-2.54
52.58%
-0.74
70.83%
-0.29
60.21%
-0.45
54.20%
-1.24
173.11%
ev to sales
255.78
-
414.86
62.20%
306.26
26.18%
451.60
47.46%
38.00
-
32.62
14.15%
free cash flow per share
-9.41
-
-14.92
58.45%
-13.46
9.81%
-12.54
6.77%
-13.64
8.76%
-4.02
70.54%
-1.88
53.15%
-1.00
47.13%
free cash flow yield
-0.11
-
-0.27
149.00%
-0.32
19.80%
-0.38
19.25%
-1.47
286.27%
-1.75
19.15%
-0.91
48.07%
-0.41
54.77%
graham net net
-0.99
-
14.94
1,615.43%
23.50
57.26%
11.03
53.07%
-3.15
128.57%
0.25
107.94%
0.61
143.23%
-0.22
136.04%
0.12
154.91%
graham number
12.03
-
82.30
584.34%
95.75
16.34%
63.71
33.46%
24.57
61.43%
6.56
73.29%
7.18
9.31%
2.12
70.52%
2.07
1.96%
income quality
0.96
-
0.78
18.12%
0.90
15.44%
0.84
6.53%
0.84
0.54%
1.48
76.65%
0.97
34.66%
0.95
1.65%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
interest coverage
-43.41
-
-34.19
21.23%
-37.03
8.31%
-27.76
25.04%
-32.41
16.75%
-38.71
19.43%
-41.21
6.48%
-34.05
17.38%
46.47
236.48%
interest debt per share
4.76
-
6.38
33.95%
5.75
9.83%
5.29
8.15%
4.48
15.25%
1.54
65.73%
0.75
51.19%
0.57
24.16%
0.15
74.31%
inventory turnover
invested capital
6.84
-
0.35
94.84%
0.18
48.00%
0.37
102.63%
-2.37
735.25%
2.02
185.43%
0.58
71.30%
2.66
358.28%
0.41
84.53%
market cap
189.39M
-
109.33M
42.27%
128.90M
17.91%
116.59M
9.55%
33.18M
71.54%
23.68M
28.64%
42.73M
80.47%
107.54M
151.64%
79.55M
26.03%
net current asset value
-1.46M
-
30.12M
2,169.97%
72.71M
141.42%
39.93M
45.08%
-10.46M
126.19%
3.28M
131.34%
14.02M
327.68%
-7.28M
151.97%
12.93M
277.51%
net debt to ebitda
0.12
-
-0.54
552.16%
-1.89
247.23%
0.23
112.02%
-0.04
116.75%
0.45
1,278.32%
0.69
54.52%
1.36
95.59%
0.76
44.13%
net income per share
-9.67
-
-18.08
87.01%
-13.89
23.15%
-14.01
0.86%
-15.86
13.18%
-2.69
83.01%
-1.89
29.99%
-0.98
47.86%
-0.48
50.79%
operating cash flow per share
-9.23
-
-14.14
53.12%
-12.54
11.28%
-11.83
5.73%
-13.31
12.57%
-4.00
69.99%
-1.83
54.25%
-0.94
48.72%
payables turnover
receivables turnover
14.67
-
research and ddevelopement to revenue
21.47
-
77.04
258.80%
41.86
45.66%
140.65
235.97%
24.99
-
23.78
4.85%
return on tangible assets
-1.32
-
-0.70
46.98%
-0.38
45.87%
-0.71
87.22%
-3.24
357.22%
-0.89
72.44%
-0.74
17.17%
-0.44
40.05%
-0.59
33.64%
revenue per share
0.34
-
0.16
53.55%
0.22
38.90%
0.07
69.68%
0.03
-
0.02
21.75%
roe
-14.54
-
-1.09
92.53%
-0.47
56.36%
-1.09
129.74%
9.37
961.12%
-3.79
140.45%
-1.56
58.98%
-4.87
212.90%
-1.23
74.81%
roic
1.84
-
-4.35
336.50%
-0.55
87.47%
-4.02
637.05%
5.23
230.03%
1.70
67.50%
1.38
18.59%
0.76
44.82%
2.77
262.57%
sales general and administrative to revenue
6.79
-
31.65
366.30%
20.88
34.03%
65.65
214.46%
10.59
-
8.97
15.31%
shareholders equity per share
0.66
-
16.65
2,404.22%
29.32
76.11%
12.87
56.10%
-1.69
113.14%
0.71
142.00%
1.21
70.67%
0.20
83.34%
0.39
95.33%
stock based compensation to revenue
0.92
-
9.43
925.99%
5.74
39.11%
17.65
207.26%
1.45
-
tangible asset value
1.43M
-
32.51M
2,171.63%
89.66M
175.82%
45.54M
49.21%
-6.05M
113.28%
7.33M
221.24%
25.04M
241.40%
8.98M
64.13%
27.07M
201.44%
tangible book value per share
0.66
-
16.65
2,404.22%
29.32
76.11%
12.87
56.10%
-1.69
113.14%
0.71
142.00%
1.21
70.67%
0.20
83.34%
0.39
95.33%
working capital
8.38M
-
42.20M
403.48%
89.23M
111.43%
53.92M
39.57%
-2.70M
105.00%
16.32M
705.08%
35.30M
116.25%
57.23M
62.12%
23.14M
59.57%

All numbers in USD (except ratios and percentages)